Pharmaceutical Grade Sodium Chloride
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Pertussis Vaccine Market Outlook 2023
1 Pertussis Vaccine Market Overview
1.1 Product Overview and Scope of Pertussis Vaccine
1.2 Pertussis Vaccine Segment by Type
1.2.1 Global Pertussis Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Pertussis Vaccine Segment by Application
1.3.1 Global Pertussis Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Children
1.3.3 Adults
1.4 Global Pertussis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pertussis Vaccine Revenue 2016-2027
1.4.2 Global Pertussis Vaccine Sales 2016-2027
1.4.3 Pertussis Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Pertussis Vaccine Market Competition by Manufacturers
2.1 Global Pertussis Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pertussis Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pertussis Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Pertussis Vaccine Market Competitive Situation and Trends
2.5.1 Pertussis Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pertussis Vaccine Players Market Share by Revenue
2.5.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pertussis Vaccine Retrospective Market Scenario by Region
3.1 Global Pertussis Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pertussis Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pertussis Vaccine Market Facts & Figures by Country
3.3.1 North America Pertussis Vaccine Sales by Country
3.3.2 North America Pertussis Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pertussis Vaccine Market Facts & Figures by Country
3.4.1 Europe Pertussis Vaccine Sales by Country
3.4.2 Europe Pertussis Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pertussis Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Pertussis Vaccine Sales by Region
3.5.2 Asia Pacific Pertussis Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pertussis Vaccine Market Facts & Figures by Country
3.6.1 Latin America Pertussis Vaccine Sales by Country
3.6.2 Latin America Pertussis Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Pertussis Vaccine Sales by Country
3.7.2 Middle East and Africa Pertussis Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pertussis Vaccine Historic Market Analysis by Type
4.1 Global Pertussis Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Pertussis Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Pertussis Vaccine Price by Type (2016-2021)
5 Global Pertussis Vaccine Historic Market Analysis by Application
5.1 Global Pertussis Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Pertussis Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Pertussis Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Pertussis Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Corporation Information
6.4.2 Wuhan Institute of Biological Products Description and Business Overview
6.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Minhai Biotechnology
6.6.1 Minhai Biotechnology Corporation Information
6.6.2 Minhai Biotechnology Description and Business Overview
6.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
6.6.5 Minhai Biotechnology Recent Developments/Updates
7 Pertussis Vaccine Manufacturing Cost Analysis
7.1 Pertussis Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pertussis Vaccine
7.4 Pertussis Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pertussis Vaccine Distributors List
8.3 Pertussis Vaccine Customers
9 Pertussis Vaccine Market Dynamics
9.1 Pertussis Vaccine Industry Trends
9.2 Pertussis Vaccine Growth Drivers
9.3 Pertussis Vaccine Market Challenges
9.4 Pertussis Vaccine Market Restraints
10 Global Market Forecast
10.1 Pertussis Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pertussis Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pertussis Vaccine by Type (2022-2027)
10.2 Pertussis Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pertussis Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pertussis Vaccine by Application (2022-2027)
10.3 Pertussis Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pertussis Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pertussis Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pertussis Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pertussis Vaccine Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Pertussis Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pertussis Vaccine Covered in This Study
Table 5. Global Pertussis Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Pertussis Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pertussis Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pertussis Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pertussis Vaccine Average Price (USD/Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pertussis Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Pertussis Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pertussis Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pertussis Vaccine Sales by Region (2016-2021) & (M Doses)
Table 16. Global Pertussis Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Pertussis Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
Table 19. North America Pertussis Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pertussis Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Pertussis Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pertussis Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pertussis Vaccine Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Pertussis Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pertussis Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pertussis Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Pertussis Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pertussis Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pertussis Vaccine Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pertussis Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Pertussis Vaccine Sales (M Doses) by Type (2016-2021)
Table 39. Global Pertussis Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Pertussis Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pertussis Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Pertussis Vaccine Price (USD/Doses) by Type (2016-2021)
Table 43. Global Pertussis Vaccine Sales (M Doses) by Application (2016-2021)
Table 44. Global Pertussis Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Pertussis Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pertussis Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Pertussis Vaccine Price (USD/Doses) by Application (2016-2021)
Table 48. Sanofi Pasteur Corporation Information
Table 49. Sanofi Pasteur Description and Business Overview
Table 50. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 51. Sanofi Pasteur Pertussis Vaccine Product
Table 52. Sanofi Pasteur Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Pertussis Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 56. GSK Pertussis Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Mitsubishi Tanabe Pharma Corporation Information
Table 59. Mitsubishi Tanabe Pharma Description and Business Overview
Table 60. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 61. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 62. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 63. Wuhan Institute of Biological Products Corporation Information
Table 64. Wuhan Institute of Biological Products Description and Business Overview
Table 65. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 66. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 67. Wuhan Institute of Biological Products Recent Developments/Updates
Table 68. Walvax Biotechnology Corporation Information
Table 69. Walvax Biotechnology Description and Business Overview
Table 70. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 71. Walvax Biotechnology Pertussis Vaccine Product
Table 72. Walvax Biotechnology Recent Developments/Updates
Table 73. Minhai Biotechnology Corporation Information
Table 74. Minhai Biotechnology Description and Business Overview
Table 75. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 76. Minhai Biotechnology Pertussis Vaccine Product
Table 77. Minhai Biotechnology Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Pertussis Vaccine Distributors List
Table 81. Pertussis Vaccine Customers List
Table 82. Pertussis Vaccine Market Trends
Table 83. Pertussis Vaccine Growth Drivers
Table 84. Pertussis Vaccine Market Challenges
Table 85. Pertussis Vaccine Market Restraints
Table 86. Global Pertussis Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 87. Global Pertussis Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Pertussis Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Pertussis Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 91. Global Pertussis Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 92. Global Pertussis Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global Pertussis Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 95. Global Pertussis Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Pertussis Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Pertussis Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pertussis Vaccine
Figure 2. Global Pertussis Vaccine Market Share by Type in 2020 & 2027
Figure 3. Whole-cell Vaccines Product Picture
Figure 4. Acellular Vaccines Product Picture
Figure 5. Global Pertussis Vaccine Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adults
Figure 8. Global Pertussis Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Pertussis Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Pertussis Vaccine Sales 2016-2027 (M Doses)
Figure 11. Global Pertussis Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Pertussis Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Pertussis Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Pertussis Vaccine Players: Market Share by Revenue in 2020
Figure 15. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Pertussis Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Pertussis Vaccine Sales Market Share by Region in 2020
Figure 18. Global Pertussis Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Pertussis Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Pertussis Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Pertussis Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Pertussis Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Pertussis Vaccine by Application in 2020
Figure 47. Revenue Share of Pertussis Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Pertussis Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Pertussis Vaccine
Figure 50. Manufacturing Process Analysis of Pertussis Vaccine
Figure 51. Pertussis Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur GSK Mitsubishi Tanabe Pharma Wuhan Institute of Biological Products Walvax Biotechnology Minhai Biotechnology